# Clarus Lifesciences III, L.P. — Form D

Clarus Lifesciences III, L.P. of CAMBRIDGE, MA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2014-02-06. The offering totals $375.0M. Industry: Pooled Investment Fund.

## Offering

- Filed: 2014-02-06
- Form: D
- Accession: 0001597143-14-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $375.0M
- Remaining: $375.0M
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-211426

## Issuer

- Name: Clarus Lifesciences III, L.P.
- CIK: 0001597143
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 101 MAIN STREET, CAMBRIDGE, MA, 02142
- Phone: 617-949-2200

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Nicholas Galakatos | Executive Officer | New York, NY |
| Kurt C Wheeler | Executive Officer | Mt. Olive, NJ |
| Nicholas J Simon | Executive Officer | Cambridge, MA |
| Robert W Liptak | Executive Officer | Cambridge, MA |
| Dennis Henner | Executive Officer | Burlingame, CA |
| N/A Clarus Ventures III, LLC | Director | Cambridge, MA |
| N/A Clarus Ventures III GP, L.P. | Director | Cambridge, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2014-06-19](https://search.stillhousedata.com/formd/0001597143-14-000002) | D/A | $375.0M | $234.2M |

## More

- [CIK 1597143 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1597143&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001597143-14-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.